Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Galm

Showing results (21-30 of 39) with videos related to

Pageof 4
Sort By:
Annals of Hematology|October 19, 2005
Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemiaOliver Galm, Stefan Wilop, Christian Lüders, et al.
Epigenetics|June 1, 2012
A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCRRainer Claus, Stefan Wilop, Thomas Hielscher, et al.
BMC Cancer|June 3, 2008
Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancerErik Noetzel, Jürgen Veeck, Dieter Niederacher, et al.
European Journal of Haematology|October 2, 2007
Intraperitoneal application of rituximab in refractory mantle cell lymphoma with massive ascites resulting in local and systemic responseMartina Crysandt, Britta Neumann, Marco Das, et al.
Genome Research|January 10, 2002
Enzymatic regional methylation assay: a novel method to quantify regional CpG methylation densityOliver Galm, Michael R Rountree, Kurtis E Bachman, et al.
British Journal of Haematology|July 28, 2011
Array-based DNA methylation profiling in acute myeloid leukaemiaStefan Wilop, Agustín F Fernandez, Edgar Jost, et al.
Oncogene|May 5, 2005
Inactivation of the tissue inhibitor of metalloproteinases-2 gene by promoter hypermethylation in lymphoid malignanciesOliver Galm, Hiromu Suzuki, Yoshimitsu Akiyama, et al.
Cancer Research|October 18, 2002
Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human CancerManel Esteller, Mingzhou Guo, Victor Moreno, et al.
BMC Cancer|January 22, 2014
High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different originFrank Tacke, Oliver Galm, Nicolas Kanig, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 18, 2009
Targeted restoration of down-regulated DAPK2 tumor suppressor activity induces apoptosis in Hodgkin lymphoma cellsMehmet Kemal Tur, Inga Neef, Edgar Jost, et al.
Pageof 4

Showing results (21-30 of 39) with videos related to

Sort By:
Pageof 4
Annals of Hematology|October 19, 2005
Clinical implications of aberrant DNA methylation patterns in acute myelogenous leukemiaOliver Galm, Stefan Wilop, Christian Lüders, et al.
Epigenetics|June 1, 2012
A systematic comparison of quantitative high-resolution DNA methylation analysis and methylation-specific PCRRainer Claus, Stefan Wilop, Thomas Hielscher, et al.
BMC Cancer|June 3, 2008
Promoter methylation-associated loss of ID4 expression is a marker of tumour recurrence in human breast cancerErik Noetzel, Jürgen Veeck, Dieter Niederacher, et al.
European Journal of Haematology|October 2, 2007
Intraperitoneal application of rituximab in refractory mantle cell lymphoma with massive ascites resulting in local and systemic responseMartina Crysandt, Britta Neumann, Marco Das, et al.
Genome Research|January 10, 2002
Enzymatic regional methylation assay: a novel method to quantify regional CpG methylation densityOliver Galm, Michael R Rountree, Kurtis E Bachman, et al.
British Journal of Haematology|July 28, 2011
Array-based DNA methylation profiling in acute myeloid leukaemiaStefan Wilop, Agustín F Fernandez, Edgar Jost, et al.
Oncogene|May 5, 2005
Inactivation of the tissue inhibitor of metalloproteinases-2 gene by promoter hypermethylation in lymphoid malignanciesOliver Galm, Hiromu Suzuki, Yoshimitsu Akiyama, et al.
Cancer Research|October 18, 2002
Hypermethylation-associated Inactivation of the Cellular Retinol-Binding-Protein 1 Gene in Human CancerManel Esteller, Mingzhou Guo, Victor Moreno, et al.
BMC Cancer|January 22, 2014
High prevalence of Y-box protein-1/p18 fragment in plasma of patients with malignancies of different originFrank Tacke, Oliver Galm, Nicolas Kanig, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|July 18, 2009
Targeted restoration of down-regulated DAPK2 tumor suppressor activity induces apoptosis in Hodgkin lymphoma cellsMehmet Kemal Tur, Inga Neef, Edgar Jost, et al.
Pageof 4